相关实验视频
Updated: Jul 23, 2025

05:51
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
13.2K
联素-6在动脉样硬化中的信号传递:从分子机制到临床结果
Charalampos Papastamos1, Alexios S Antonopoulos1, Spyridon Simantiris1
11st Cardiology Department, National and Kapodistrian University of Athens, Hippokration General Hospital, Athens, Greece.
Current topics in medicinal chemistry
|July 19, 2023
概括
互白素-6 (IL-6) 驱动动动脉瘤风险和冠状动脉疾病. 向IL-6可能提供一种选择性方法,以减少残留炎症风险并阻碍疾病的进展.
科学领域:
- 免疫学 免疫学 免疫学
- 心血管医学 心血管医学
- 炎症生物学 炎症生物学
背景情况:
- 洲际蛋白-6 (IL-6) 是一种关键的细胞因子,它能将免疫力,炎症和心血管疾病联系起来.
- 升高的IL-6水平与动脉血事件和冠状动脉疾病的风险增加相关.
- 动脉样硬化的"炎症假设"得到了广泛的临床和遗传证据的支持,这些证据涉及IL-6.
结论:
- IL-6是心血管疾病残留炎症风险的重要生物标志物.
- 向IL-6可能提供比更广泛的方法更有选择性和有效的抗炎疗法.
- 对IL-6抑制的进一步研究可能会导致冠状动脉疾病的新疗法.
相关概念视频
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
Atherosclerosis I: Introduction
11
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
11
Inflammation
53.9K
Overview
53.9K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
13
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Coronary Artery Disease II: Pathophysiology
13
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
13

